Skip to main content
German Center for Infection Research
  • Research
    • Back
    • Bridging Topics
    • Research Areas
    • Infrastructures
    • Working Groups
    • Projects
    • African Partner Institutions
    • Clinical Trials
    • Publications
  • Translation
    • Back
    • Developing Medication
    • Successful Translation
    • Collaborations
    • German Centers for Health Research
  • DZIF Academy
  • Newsroom
    • Back
    • News
    • Media Centre
    • Press Office
    • Events
    • Jobs
  • About us
    • Back
    • Portrait
    • DZIF Structure and Bodies
    • Partner Sites
    • Executive Board
    • DZIF Patient Advisory Board
    • Staff
    • Main Office
    • Donations
  • De
  • |
  • En

Search

Breadcrumb

  1. Home
  2. Search
Sep 2020
J Proteome Res

Rapid Response to Pandemic Threats: Immunogenic Epitope Detection of Pandemic Pathogens for Diagnostics and Vaccine Development Using Peptide Microarrays

Autoren
Heiss K et al.
Sep 2020
Lancet Infect Dis

Safety and immunogenicity of co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in Gabonese adults: a randomised, controlled, double-blind, phase 1 dose-escalation trial

Autoren
Adegnika AA et al.
Sep 2020
Int J Mol Sci

HCV Glycoprotein Structure and Implications for B-Cell Vaccine Development

Autoren
Ströh LJ
Krey T
Heidelberg University

Immune control of HIV-1

The human immune system can effectively prevent and control viral infections. While many viruses can be neutralized and eliminated from the human body, other viruses persist after infection. However, they are often controlled throughout the entire human lifespan (e.g. certain herpes viruses like CMV ...

Staphylococcus aureus

© NIAID

© NIAID
Jan 19 2021

Hope for a vaccination against Staphylococcus areus infections?

Staphylococcus aureus (S. aureus) ranks among the globally most important causes of infections in humans and is considered a dreaded hospital pathogen. Active and passive immunisation against multi

23 Feb 2021
Workshop

Germany

internal

DZG Online Seminar Series: Translating Science into Clinical Practice

Coronavirus

© Fusion Medical Animation

© Fusion Medical Animation
Jan 8 2021

Start of second study phase of the vector vaccine against COVID-19 postponed

The further development of the vector vaccine MVA-SARS-2-S against COVID-19 by IDT Biologika GmbH and the German Center for Infection Research (DZIF) is postponed. The vector vaccine has been

SARS-CoV-2

© NIAID

© NIAID
Dec 18 2020

New SARS-CoV-2 neutralizing antibody enters clinical phase

Cologne, Marburg, Braunschweig and Ingelheim, Germany, 18 December 2020 – Cologne University Hospital (UKK), University of Marburg (UMR), the German Center for Infection Research (DZIF) and Boehringer

TherVacB: A therapeutic vaccine against hepatitis B

The Munich DZIF team led by Prof. Ulrike Protzer is developing a novel therapeutic approach to cure chronic hepatitis B. Researchers at Helmholtz Munich and Technical University of Munich (TUM) found
Prof. Stephan Becker and Prof. Gerd Sutter

© Rolf K. Wegst und LMU München

© Rolf K. Wegst und LMU München
Dec 8 2020

DZIF prizes for translational infection research go to vaccine researchers

This year, the German Center for Infection Research (DZIF) is honouring two researchers who have been engaged in virus research for many years and are currently actively working on a vaccine against

Pagination

Previous page ‹‹
Seite 24 Seite 25 Seite 26 Seite 27 Current page 28 Seite 29 Seite 30 Seite 31 Seite 32
Next page ››

Sitemap

  • Research
  • Translation
  • DZIF Academy
  • Newsroom
  • About us

At one click

  • Jobs
  • Media Centre
  • Press releases
  • Press contact
  • Glossary
  • Donations

Newsletter Subscription

Contact

Main Office of the DZIF e. V.
Inhoffenstraße 7
38124 Braunschweig
​

E-Mail Send mail

Fußbereichsmenü

  • DZIF Portal (internal)
  • Whistleblower system
  • Imprint
  • Privacy policy
  • Log in
  • Manage cookie consent
German Centers for Health Research
Supported by the Federal Ministry of Research, Technology and Space and the participating federal states